Innovation + Divide...
Consumer Goods: Consumer Non-Durables
Carlisle Companies Inc. (CSL: NYSE)
$47.95 -0.88 | -1.80%
02/10/12 - 11:55 AM ET
31.82K / 292.60K
Vol / Avg. Vol:48.16 / 48.83
Open / Prev. Close:47.50 - 48.30
Today's Range:29.88 - 50.60
52 Wk Range:10.23%
Performance YTD:TheStreet Rating:
Portfolios with CSL
- Portfolio NameUser Type
- ContributorTop-Rated Industrial Conglo...
- ProTudor Investment
- ContributorDividend Stocks for the Wee...
- ProAmana Income Fund - AMANX
- UserTop Dividend Increasers for...
- Usermarkinhi Portfolio 1
- ProLord Abbett Small-Cap Value...
- UserCGIC
- Userazhester Portfolio 1
- ProDiversified Mid-Cap Value I...
Latest CSL Headlines from TheStreet
- Carlisle's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.02.12 | 01:02 pm
- Carlisle Cos. Wraps Tri-Star Electronics Purchase 12.02.11 | 04:12 pm
- Carlisle Companies Stock To Go Ex-dividend Tomorrow (CSL) 11.08.11 | 08:11 am
- Carlisle Companies Inc. Stock Upgraded (CSL) 10.27.11 | 07:10 am
- Carlisle's CEO Discusses Q3 2011 Results - Earnings Call Transcript 10.25.11 | 12:10 pm
- FedEx, UPS: Analysts' New Ratings 09.02.11 | 09:09 am
- Carlisle Companies Inc. Stock Downgraded (CSL) 08.30.11 | 09:08 am
- Carlisle Companies Stock To Go Ex-dividend Monday (CSL) 08.12.11 | 10:08 am
- Carlisle Buys German Roofing Company PDT Phoenix 08.01.11 | 12:08 pm
- Carlisle Companies' CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.26.11 | 02:07 pm
Press Releases for CSL
- International Phase I Trial Results Of Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) Show All Pharmacokinetic Parameters Significantly Improved In Patients With Severe Hemophilia B - PR Newswire 02.02.12 | 09:02 am
- Carlisle Companies Reports $0.63 Earnings Per Share From Continuing Operations For The Fourth Quarter, An 80% Increase From The Prior Year - Business Wire 02.02.12 | 06:02 am
- Carlisle Companies Declares Regular Quarterly Dividend - Business Wire 02.01.12 | 10:02 am
- Carlisle Companies To Announce 4th Quarter 2011 Earnings On February 2, 2012 - Business Wire 01.17.12 | 09:01 am
- First Clinical Trial Site Initiated In CSL Behring Phase II/III Pivotal Study Of Recombinant Fusion Protein Linking Coagulation Factor IX With Recombinant Albumin - PR Newswire 01.12.12 | 09:01 am
- Carlisle Completes The Sale Of PDT’s Rubber Components Unit - Business Wire 01.02.12 | 11:01 am
- Carlisle Completes The Acquisition Of Tri-Star Electronics International, Inc. - Business Wire 12.02.11 | 11:12 am
- Carlisle To Sell German Rubber Components Unit - Business Wire 11.22.11 | 12:11 pm
- Carlisle Companies To Present November 15th At Citi’s U.S. Small/Mid Cap Conference In Las Vegas - Business Wire 11.14.11 | 09:11 am
- Carlisle To Acquire Tri-Star Electronics International, Inc. - Business Wire 11.14.11 | 08:11 am
Partner Headlines for CSL
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.25.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.19.12 | 09:01 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 01.12.12 | 09:01 am
- 3 Dividend Plays From The Rubber And Plastics Industry - Seeking Alpha 11.06.11 | 08:11 am
- 3M Company Earnings Preview: Analysts Expect Higher EPS, Revenue - Benzinga 10.20.11 | 01:10 pm
- Carlisle Companies - Value - Zacks 06.08.11 | 01:06 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 05.05.11 | 09:05 am
- UPDATE 1-Carlisle net drops on charges, raw material costs - Reuters 02.07.11 | 07:02 am
- Carlisle Companies - Value - Zacks 01.14.11 | 01:01 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 01.05.11 | 09:01 am
